alpha-L-Fucp-(1->2)-beta-D-Galp-(1->3)-D-GalpNAc

Term ID

CHEBI:84728

Synonyms

6-deoxy-alpha-L-galactopyranosyl-(1->2)-beta-D-galactopyranosyl-(1->3)-2-(acetylamino)-2-deoxy-D-galactopyranose
6-deoxy-alpha-L-galactopyranosyl-(1->2)-beta-D-galactopyranosyl-(1->3)-2-acetamido-2-deoxy-D-galactopyranose
alpha-L-Fuc-(1->2)-beta-D-Gal-(1->3)-D-GalNAc
alpha-L-fucopyranosyl-(1->2)-beta-D-galactopyranosyl-(1->3)-2-acetamido-2-deoxy-D-galactopyranose
alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->3)-N-acetyl-D-galactosamine
alpha-L-Fucp-(1-2)-beta-D-Galp-(1-3)-D-GalpNAc
alphaFuc(1-2)betaGal(1-3)GalNAc

Definition

An amino trisaccharide consisting of α-L-fucopyranose, β-D-galactopyranose and N-acetyl-D-galactopyranosamine residues joined in sequence with a (1→2)- and a (1→3)-linkage, respectively.

References

glygen:G46868TY
glytoucan:G46868TY
pubmed:19695255
reaxys:19536487

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from alpha-L-Fucp-(1->2)-beta-D-Galp-(1->3)-D-GalpNAc

Phenotype where environments contain alpha-L-Fucp-(1->2)-beta-D-Galp-(1->3)-D-GalpNAc

Phenotype modified by environments containing alpha-L-Fucp-(1->2)-beta-D-Galp-(1->3)-D-GalpNAc

Phenotype affecting alpha-L-Fucp-(1->2)-beta-D-Galp-(1->3)-D-GalpNAc

Human Disease Model